Blog/FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers
FDA Releases Guidance on Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers
Oct 8, 2024
In October 2024, the U.S. Food and Drug Administration issued a final guidance titled Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers. https://www.fda.gov/media/166215/download
This guidance provides recommendations on the use of electronic systems, electronic records and electronic signatures in food, medical product, tobacco product, and new animal drug clinical investigations.
This guidance finalizes the draft guidance for industry issued in March 2023, titled Use of Electronic Records and Electronic Signatures in Clinical Investigations Under 21 CFR Part 11–Questions and Answers.
Flex Databases has analyzed the guidance and is ready to share how we support our Clients being the trusted software development vendor.
Regulated entities are responsible for ensuring that electronic records meet applicable part 11 requirements. When determining the suitability of the IT service and IT service provider, regulated entities should consider the following regarding the IT service provider’s ability to ensure the authenticity, integrity, and confidentiality of clinical investigation records and data:
FDA requirement
Flex Databases guarantees
Processes and procedures the IT service provider has in place for validation of specific IT services to be used in the clinical investigation
Fully validated system with the validation deliverables package Support during User Acceptance Testing
Ability of the IT service provider to generate accurate and complete copies of records and to provide access to data for as long as the records are required to be retained by applicable regulations
Retention period is negotiated and captured in the contract. All the data stored in the system is subject to full backup and is stored as long as required.
Processes and procedures the IT service provider has for data migration, data backup, recovery, contingency plans, and retaining records and making them available for FDA inspection for as long as the records are required to be retained by applicable regulations
Always ready to share our SOPs, including the backup procedure, Disaster Recovery and Business Continuity Plans and Reports, data migration working practice and relevant deliverables
Ability to provide secure, computer-generated, time-stamped audit trails of users’ actions and changes to data
Audit trail captures all actions performed in the system
Ability to secure and protect the confidentiality of data at rest and in transit (as appropriate for the content and nature of the record)
All traffic into and out of the Flex Databases Platform is encrypted, all backups are encrypted-in-transit to the separate data center and are encrypted-at-rest while stored at that location.
Blog
Nov 19, 2024
How to Choose Pharmacovigilance (PV) Software for Clinical Trial Management
Pharmacovigilance (PV) is a critical aspect of drug safety, focusing on detecting, assessing, understanding, and preventing adverse drug reactions or other drug-related problems. As global regulatory requirements for drug safety evolve, adopting reliable pharmacovigilance software has become essential for ensuring compliance and improving operational efficiency. Selecting the right PV software can significantly impact your organization’s […]
Clinical Trial Management Systems (CTMS) and Electronic Data Capture (EDC) systems are critical to the effective management of clinical trials. By integrating CTMS and EDC, organizations can streamline processes, enhance data quality, and improve overall efficiency. Here are five key tips to ensure a successful CTMS and EDC integration. Effortless Integration of Flex Databases CTMS […]
October User Group Meeting Recap: New eTMF Features, Client Feedback, and Future Plans
A new round of our traditional meetings took place in October. This time, we gathered our beloved users to discuss the use of eTMF — from everyday activities to audit preparation. We reviewed how newly released features, such as duplicate search, quality review, and metadata notifications, influence TMF workflows. It appeared not everyone was using […]
We’re excited to announce that Flex Databases will be participating in this prestigious event from November 4–6, 2024. Join us to explore our innovative solutions! Connect with Kristina Kojoushko at the event to learn more about our services, including eTMF, CTMS, Pharmacovigilance Software and more. 📅 Schedule a meeting with Kristina at kristina.kojoushko@flexdatabases.com or reach […]
Get in touch to discuss compliance, implementation, demos, pricing
We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.
Thank you for your interest.
Thank you for your interest. We are working on your request and will come back to you in the next 24 hours.
